d-fructose-1,6-diphosphate

D-fructose-1,6-diphosphate (D-fructose-1,6-diphosphate), also known as Fosfructose, is a cytoprotective natural sugar phosphate. It functions by promoting anaerobic glycolysis, which generates adenosine triphosphate (ATP) under ischemic conditions. This compound holds potential for research in cardiovascular ischemia, sickle cell anemia, and asthma.

Esafosfan trisodium (FDP trisodium) is a cytoprotective natural sugar phosphate for the potential treatment of sickle cell anemia, cardiovascular ischemia and asthma. It acts by stimulating anaerobic glycolysis which generates adenosine triphosphate under ischemic conditions.

Fosfructose trisodium octahydrate is an intermediate in carbohydrate metabolism, participating in glycolysis and gluconeogenesis. It acts as an inhibitor of bacterial acetate kinase and an allosteric activator of PKM2, exhibiting neuroprotective effects.

Aldolase is a glycolytic enzyme and component of the VATPase complex that catalyzes the reversible cleavage of fructose 1,6-bisphosphate into dihydroxyacetone phosphate and D-glyceraldehyde 3-phosphate. Aldolase plays a critical role in cellular energy metabolism, metabolic flux regulation, and enzymatic studies of glycolysis and related pathways.